Achieve Life Sciences Inc... (ACHV)
NASDAQ: ACHV
· Real-Time Price · USD
2.54
-0.01 (-0.39%)
At close: Aug 15, 2025, 3:59 PM
2.46
-3.34%
After-hours: Aug 15, 2025, 07:49 PM EDT
Achieve Life Sciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -46.16M | -39.83M | -32.94M | -27.54M | -27.32M | -29.82M | -35.57M | -41.54M | -43.77M | -42.35M | -38.27M | -31.88M | -32.73M | -33.15M | -30.73M | -27.8M | -19.41M |
Depreciation & Amortization | 234K | 229K | 228K | 229K | 227K | 228K | 236K | 233K | 234K | 236K | 233K | 239K | 246K | 250K | 252K | 256K | 258K |
Stock-Based Compensation | 6.27M | 5.33M | 4.07M | 3.91M | 3.64M | 3.44M | 4.23M | 3.88M | 3.53M | 3.27M | 2.99M | 2.69M | 2.47M | 2.19M | 2.09M | 1.84M | 1.53M |
Other Working Capital | 499K | -37K | -387K | 634K | -87K | 292K | -2.13M | -1.03M | -914K | -720K | 2.94M | -721K | 97K | 725K | -92K | 2.02M | 491K |
Other Non-Cash Items | 3.96M | 6.02M | 6.71M | 5.87M | 4.37M | 2.6M | 1.76M | 1.32M | 1.2M | 1.2M | 2.35M | 2.61M | 2.33M | 2.06M | 542K | -21.2K | -38.86K |
Deferred Income Tax | n/a | n/a | -152K | -152K | -152K | -152K | n/a | n/a | n/a | n/a | -1.46M | -1.46M | -1.46M | -1.46M | 62K | 62K | 62K |
Change in Working Capital | 2.08M | 1.41M | 69K | 906K | -694K | -778K | -1.91M | -1.33M | -269K | 99K | 2.54M | -640K | -70K | 1.23M | 1.64M | 3.32M | 2.14M |
Operating Cash Flow | -35.57M | -29.77M | -24.95M | -19.71M | -21.46M | -24.48M | -31.26M | -37.43M | -39.07M | -37.55M | -31.62M | -29.01M | -29.77M | -29.44M | -26.7M | -22.34M | -15.46M |
Capital Expenditures | n/a | n/a | -6K | -21K | -21K | -21K | -15K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3K | -15K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -51.25M | -47.89M | -46.96M | -46.57M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 27.36M | 12.65M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 13.66M | 13.66M | 13.66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -10.23M | -21.58M | -33.3M | -46.59M | -21K | -21K | -15K | n/a | n/a | n/a | -1K | -1K | -1K | -1K | n/a | -3K | -15K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | -30K | -30K | -30K | -30K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -7.55M | -7.55M | -8.2M | -84K | -40K | 7K | -23K | 103K | 126K | 83K | 15.01M | 14.89M | 15.04M | 15.27M | -1.09M | 1.39M | 1.87M |
Financial Cash Flow | -7.58M | 48.53M | 47.84M | 55.96M | 71.34M | 15.28M | 32.99M | 33.12M | 19.25M | 19.3M | 16.51M | 16.39M | 36.47M | 36.61M | 37.62M | 52.23M | 32.96M |
Net Cash Flow | -53.38M | -2.79M | -10.38M | -10.31M | 49.88M | -9.22M | 1.72M | -4.31M | -19.82M | -18.25M | -15.12M | -12.62M | 6.7M | 7.17M | 10.92M | 29.89M | 17.48M |
Free Cash Flow | -35.57M | -29.77M | -24.95M | -19.73M | -21.48M | -24.5M | -31.27M | -37.43M | -39.07M | -37.55M | -31.62M | -29.01M | -29.77M | -29.44M | -26.7M | -22.35M | -15.48M |